跳到正文
原文
Endpoints News 生物医药· Kyle LaHucik·· 2026-10-13AI 评分30

Apogee高管加入Paragon以扩展其研发与公司创建引擎

Apogee execs join Paragon to scale its R&D, company creation engine

AI 导读

Apogee在被Abbvie以109亿美元收购后,其CEO Michael Henderson及五名高管加入Paragon Labs。此举旨在扩展Paragon的研发(R&D)及公司创建引擎。

正文

Michael Henderson, Paragon Labs CEO (Brian Benton Photography)

October 13, 2026 07:00 AM EDT

Af­ter $10.9B ex­it to Ab­b­Vie, Apogee ex­ecs join Paragon to scale its R&D, com­pa­ny cre­ation en­gine

Some peo­ple would think about tak­ing a break for sev­er­al quar­ters af­ter sell­ing a biotech for $10.9 bil­lion. Michael Hen­der­son and five …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Think we're worth reading - tell Google.

Confirm Endpoints as a trusted biopharma news source

Confirm on Google

ENDPOINTS CAREERS

来源:Endpoints News 生物医药 · endpoints.news